5‐Aminolevulinic Acid‐induced Protoporphyrin IX Levels in Tissue of Human Malignant Brain Tumors
- 21 August 2010
- journal article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 86 (6), 1373-1378
- https://doi.org/10.1111/j.1751-1097.2010.00799.x
Abstract
Protoporphyrin IX (PpIX) produced from exogenous, orally administered 5-aminolevulinic acid (ALA) displays high tumor-selective uptake and is being successfully employed for fluorescence-guided resection (FGR) of human malignant gliomas. Furthermore, the phototoxicity of PpIX can be utilized for photodynamic therapy (PDT) of brain tumors, which has been shown previously. Here, the absolute PpIX concentration in human brain tissue was investigated following oral ALA administration (20 mg kg−1 b.w.). An extraction procedure was used to quantify PpIX in macroscopic tissue samples, weighing 0.013–0.214 g, obtained during FGR. The PpIX concentration was significantly higher in vital grade IV tumors (5.8 ± 4.8 μm, mean ± SD, range 0–28.2 μm, n = 8) as compared with grade III tumors (0.2 ± 0.4 μm, mean ± SD, range 0–0.9 μm, n = 4). There was also a large heterogeneity within grade IV tumors with PpIX displaying significantly lower levels in infiltration zones and necrotic regions as compared with vital tumor parts. The average PpIX concentration in vital grade IV tumor parts was in the range previously shown sufficient for PDT-induced tissue damage following irradiation. However, the feasibility of PDT for grade III brain tumors and for grade IV brain tumors displaying mainly necrotic tissue areas without solid tumor parts needs to be further investigated.This publication has 39 references indexed in Scilit:
- In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapyJournal of Biomedical Optics, 2008
- ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trialLasers in Medical Science, 2007
- Diffuse glioma growth: a guerilla warActa Neuropathologica, 2007
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶Photochemistry and Photobiology, 2004
- Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶Photochemistry and Photobiology, 2004
- 5-Aminolevulinic Acid Photosensitization of Dysplastic Barrett's Esophagus: A Pharmacokinetic StudyPhotochemistry and Photobiology, 1999
- Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5‐aminolevulinic acid in mice bearing mammary carcinomaInternational Journal of Cancer, 1992
- An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivoPhysics in Medicine & Biology, 1986